Dữ liệu Xếp hạng Học thuật WoS SCIE & CAS
Bảng Xếp hạng Tạp chí Khoa học Toàn cầu
Khám phá thứ bậc học thuật, đối chiếu chỉ số Clarivate Impact Factor, phân hạng Web of Science Q1–Q4 và phân vùng CAS.
Hiển thị 76–100 của 127 tạp chí khoa học quốc tế (Pharmacy)
| Hạng | Tên Tạp chí & Mã ISSN | Impact Factor | H-Index | Phân hạng WoS | Scopus SJR | Phân vùng CAS | Tự trích dẫn | Số bài/năm | Nhà xuất bản |
|---|---|---|---|---|---|---|---|---|---|
| #76 | Annals of Pharmacotherapy ISSN: 1060-0280 / 1542-6270 | 2.5 | 129 | Q3 | 0.815Q2 | CAS Tier 3 | 4.3% | 179 | SAGE Publications Inc. |
| #77 | Cancer Chemotherapy and Pharmacology ISSN: 0344-5704 / 1432-0843 | 2.5 | 132 | Q3 | 0.851Q2 | CAS Tier 4 | 3.7% | 162 | Springer Berlin Heidelberg |
| #78 | Critical Reviews in Therapeutic Drug Carrier Systems ISSN: 0743-4863 / 2162-660X | 2.5 | 88 | Q3 | 0.469Q2 | CAS Tier 4 | 13.3% | 18 | Begell House Inc. |
| #79 | Journal of the American Pharmacists Association ISSN: 1544-3191 / 1544-3450 | 2.4 | 78 | Q3 | 0.809Q1 | CAS Tier 4 | 16% | 203 | American Pharmacists Association |
| #80 | European Journal of Drug Metabolism and Pharmacokinetics ISSN: 0378-7966 / 2107-0180 | 2.3 | 52 | Q3 | 0.632Q2 | CAS Tier 3 | 5.3% | 69 | Springer International Publishing |
| #81 | Biopharmaceutics & Drug Disposition ISSN: 0142-2782 / 1099-081X | 2.2 | 72 | Q3 | 0.54Q2 | CAS Tier 4 | 0% | 38 | John Wiley and Sons Ltd |
| #82 | Drug Metabolism and Pharmacokinetics ISSN: 1347-4367 / 1880-0920 | 2.2 | 81 | Q3 | 0.626Q2 | CAS Tier 4 | 7.4% | 56 | Japanese Society for the Study of Xenobiotics |
| #83 | Journal of Clinical Pharmacology ISSN: 0091-2700 / 1552-4604 | 2.2 | 137 | Q3 | 0.773Q2 | CAS Tier 3 | 4.2% | 157 | Wiley-Blackwell |
| #84 | Journal of Chemotherapy ISSN: 1120-009X / 1973-9478 | 2.1 | 60 | Q3 | 0.525Q3 | CAS Tier 4 | 0% | 74 | Maney Publishing |
| #85 | Planta Medica ISSN: 0032-0943 / 1439-0221 | 2.1 | 145 | Q4 | 0.456Q2 | CAS Tier 4 | 4.8% | 144 | Georg Thieme Verlag |
| #86 | Therapie ISSN: 0040-5957 / 1958-5578 | 2.1 | 46 | Q3 | 0.557Q3 | CAS Tier 4 | 27.3% | 62 | Elsevier Masson SAS |
| #87 | Anti-Cancer Drugs ISSN: 0959-4973 / 1473-5741 | 2 | 106 | Q4 | 0.506Q3 | CAS Tier 4 | 0% | 141 | Lippincott Williams and Wilkins Ltd. |
| #88 | American Journal of Health-System Pharmacy ISSN: 1079-2082 / 1535-2900 | 1.9 | 113 | Q3 | 0.46Q1 | CAS Tier 4 | 14.3% | 207 | American Society of Health-Systems Pharmacy |
| #89 | Contemporary Clinical Trials ISSN: 1551-7144 / 1559-2030 | 1.9 | 84 | Q3 | 0.966Q1 | CAS Tier 4 | 0% | 309 | Elsevier Inc. |
| #90 | Biological & Pharmaceutical Bulletin ISSN: 0918-6158 / 1347-5215 | 1.8 | 143 | Q3 | 0.518Q2 | CAS Tier 4 | 11.8% | 260 | Pharmaceutical Society of Japan |
| #91 | Journal of International Medical Research ISSN: 0300-0605 / 1473-2300 | 1.8 | 79 | Q3 | 0.481Q3 | CAS Tier 4 | 0% | 987 | SAGE Publications Inc. |
| #92 | Iranian Journal of Pharmaceutical Research ISSN: 1735-0328 / 1726-6890 | 1.7 | 70 | Q3 | 0.425Q2 | CAS Tier 4 | 0% | 104 | Iranian Journal of Pharmaceutical Research |
| #93 | Farmacia ISSN: 0014-8237 | 1.6 | 34 | Q4 | 0.292Q2 | CAS Tier 4 | 64.3% | 150 | Romanian Society for Pharmaceutical Sciences |
| #94 | International Journal of Medicinal Mushrooms ISSN: 1521-9437 | 1.6 | 47 | Q4 | 0.364Q3 | CAS Tier 4 | 14.3% | 98 | Begell House Inc. |
| #95 | Journal of Asian Natural Products Research ISSN: 1028-6020 / 1477-2213 | 1.6 | 56 | Q3 | 0.294Q2 | CAS Tier 4 | 0% | 135 | Taylor and Francis Ltd. |
| #96 | Chemotherapy ISSN: 0009-3157 / 1421-9794 | 1.4 | 64 | Q4 | 0.442Q3 | CAS Tier 4 | 0% | 34 | S. Karger AG |
| #97 | Personalized Medicine ISSN: 1741-0541 / 1744-828X | 1.2 | 40 | Q4 | 0.357Q3 | CAS Tier 4 | 0% | 48 | Future Medicine Ltd. |
| #98 | Journal of Clinical Pharmacy and Therapeutics ISSN: 0269-4727 / 1365-2710 | 1.1 | 90 | Q4 | 0.537Q3 | CAS Tier 4 | 0% | 209 | Wiley-Blackwell Publishing Ltd |
| #99 | Medical Letter on Drugs and Therapeutics ISSN: 0025-732X / 1523-2859 | 1.1 | 22 | Q4 | 0.257Q3 | CAS Tier 4 | 42.9% | 50 | Medical Letter Inc. |
| #100 | Journal of Pharmacy Practice and Research ISSN: 1445-937X | 1 | 27 | Q4 | 0.32Q2 | CAS Tier 4 | 10% | 38 | Wiley-Blackwell |